Organogenesis Holdings Inc. (ORGO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 2.5700 |
| Open | 2.5500 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 2.4450 - 2.5550 |
| 52-week range | 1.9600 - 4.7050 |
| Volume | |
| Avg. volume | 1,202,696 |
| Market cap | 327.453M |
| Beta (5Y monthly) | 1.66 |
| PE ratio (TTM) | 61.75 |
| EPS (TTM) | 0.0400 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 4.17 |
Simply Wall St.With 38% ownership, Organogenesis Holdings Inc. (NASDAQ:ORGO) insiders have a lot riding on the company's future
Key Insights Significant insider control over Organogenesis Holdings implies vested interests in company growth 52% of...
GlobeNewswireOrganogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference
CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the Truist Securities MedTech Conference, which is being held at the InterContinental Boston in Boston, MA on Tuesday, June 18th. Management will participate in 1x
Simply Wall St.Organogenesis Holdings First Quarter 2024 Earnings: Beats Expectations
Organogenesis Holdings ( NASDAQ:ORGO ) First Quarter 2024 Results Key Financial Results Revenue: US$110.0m (up 2.2...
© 2024 Yahoo. All rights reserved.